Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 342

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 342
---
 was a director on our board of directors prior to the completion of the Kintara Merger, and was appointed as a member of our board of directors to serve following the Kintara Merger. Dr. James Bianco, our Chief Executive Officer, did not receive any compensation for his service as a member of our board of directors for the fiscal year ended December 31, 2024. Dr. Bianco’s compensation for service as an employee for fiscal year 2024 is presented in the section titled “Executive Compensation—Summary Compensation Table” above. 

108

    Name
     
    Year
     
    Fees Earnedor Paid in Cash

    OptionAwards(8)

    Total ($)

    James Manuso, Ph.D(1)
     
    2024
     
    $
    14,750

    $
    -

    $
    14,750

    Alan List, M.D.(2)
     
    2024
     
    $
    13,875

    $
    -

    $
    13,875

    George Ng.(3)
     
    2024
     
    $
    14,125

    $
    -

    $
    14,125

    Robert Hoffman(4)
     
    2024
     
    $
    11,408

    $
    -

    $
    11,408

    Robert J. Toth, Jr.(5)
     
    2024
     
    $
    49,101

    $
    -

    $
    49,101

    Laura Johnson (6)
     
    2024
     
    $
    48,302

    $
    -

    $
    48,302

    Tamara A. Favorito(7)
     
    2024
     
    $
    51,097

    $
    -

    $
    51,097

(1)Dr. Manuso was appointed to our board of directors on October 18, 2024 in connection with the consummation of the Kintara Merger.

(2)Dr. List was appointed to our board of directors on October 18, 2024 in connection with the consummation of the Kintara Merger.

(3)Mr. Ng. was appointed to our board of directors on October 18, 2024 in connection with the consummation of the K